Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Curvebeam AI Ltd. ( (AU:CVB) ) has provided an announcement.
CurveBeam AI has scheduled the release of its Appendix 4C quarterly cash flow report for the period ended 31 December 2025 ahead of the market open on 30 October 2025, and will host an investor webinar on 29 January 2026 to discuss its Q2 FY26 results. The online briefing will be led by CEO and Managing Director Greg Brown, along with senior executives Arun Singh and Ura Auckland, offering shareholders and investors a forum to hear management’s commentary and submit questions, underscoring the company’s ongoing emphasis on investor engagement and transparency around its financial performance and operational progress.
The most recent analyst rating on (AU:CVB) stock is a Hold with a A$0.15 price target. To see the full list of analyst forecasts on Curvebeam AI Ltd. stock, see the AU:CVB Stock Forecast page.
More about Curvebeam AI Ltd.
CurveBeam AI Limited (ASX: CVB) is a fully integrated developer and manufacturer of specialised point-of-care medical CT imaging equipment, complemented by AI-driven SaaS clinical assessment solutions for managing musculoskeletal conditions. Its flagship HiRise CT scanner performs both weight-bearing and traditional non–weight-bearing scans, offering advantages over conventional CT and MRI systems. The company employs more than 70 staff, with corporate, AI and IP functions based in Melbourne, Australia, and global operations headquartered in Hatfield, Pennsylvania, USA.
Average Trading Volume: 1,607,345
Technical Sentiment Signal: Sell
Current Market Cap: A$37.9M
For detailed information about CVB stock, go to TipRanks’ Stock Analysis page.